A series of papers presented at the Second International Symposium on recent pharmacological and clinical data on the role of Fraxiparine evaluates the drug's validity in practical clinical work in patients with hemostasis and thrombosis. Begins with a discussion of the prophylaxis of thrombosis in surgery and medicine. It goes on to cover treatment of deep-vein thrombosis (DVT) and pulmonary embolism. Final chapters cover the biology and pharmacology of low-molecular-weight (LMW) heparins.